Intraoperative abdominal ultrasonography-guided large volume ethanol injection for hepatocellular carcinoma

2001 ◽  
Vol 120 (5) ◽  
pp. A482-A482
Author(s):  
R MONDRAGONSANCHEZ ◽  
A GARDUOLOPEZ ◽  
H MURRIETA ◽  
M FRIASMENDIVIL ◽  
R ESPEJO ◽  
...  
2001 ◽  
Vol 120 (5) ◽  
pp. A482
Author(s):  
Ricardo J. Mondragon-Sanchez ◽  
Ana Lilia L. Gardu&o-Lopez ◽  
Hector Murrieta ◽  
Mauricio Frias-Mendivil ◽  
Rubi Espejo ◽  
...  

2005 ◽  
Vol 4 (3) ◽  
pp. 200-203
Author(s):  
Ricardo Mondragón-Sánchez ◽  
Ana Lilia Garduño-López ◽  
Elvira Gómez-Gómez ◽  
Mauricio Frias-Mendivil ◽  
Alejandro Mondragón-Sánchez ◽  
...  

1992 ◽  
Vol 159 (6) ◽  
pp. 1344-1345
Author(s):  
J P Joly ◽  
T Yzet ◽  
J L Dupas ◽  
J P Capron

BMC Surgery ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Qiang Wang ◽  
Shu Chen ◽  
Jun Yan ◽  
Torkel Brismar ◽  
Ernesto Sparrelid ◽  
...  

Abstract Background The future liver remnant (FLR) faces a risk of poor growth in patients with cirrhosis-related hepatocellular carcinoma (HCC) after stage-1 radiofrequency-assisted ALPPS (RALPPS). The present study presents a strategy to trigger further FLR growth using supplementary radiofrequency ablation (RFA) and percutaneous ethanol injection (PEI). Methods At RALPPS stage-1 the portal vein branch was ligated, followed by intraoperative RFA creating a coagulated avascular area between the FLR and the deportalized lobes. During the interstage period, patients not achieving sufficient liver size (≥ 40%) within 2–3 weeks underwent additional percutaneous RFA/PEI of the deportalized lobes (rescue RFA/PEI) in an attempt to further stimulate FLR growth. Results Seven patients underwent rescue RFA/PEI after RALPPS stage-1. In total five RFAs and eight PEIs were applied in these patients. The kinetic growth rate (KGR) was highest the first week after RALPPS stage-1 (10%, range − 1% to 15%), and then dropped to 1.5% (0–9%) in the second week (p < 0.05). With rescue RFA/PEI applied, KGR increased significantly to 4% (2–5%) compared with that before the rescue procedures (p < 0.05). Five patients proceeded to RALPPS stage-2. Two patients failed: In one patient the FLR remained at a constant level even after four rescue PEIs. The other patient developed metastasis. Except one patient died after RALPPS stage-2, no severe complications (Clavien-Dindo ≥ IIIb) occurred among remaining six patients. Conclusions Rescue RFA/PEI may provide an alternative to trigger further growth of the FLR in patients with cirrhosis-related HCC showing insufficient FLR after RALPPS stage-1. Trial registration Retrospectively registered.


1996 ◽  
Vol 14 ◽  
pp. 89-94
Author(s):  
Masaaki Ebara ◽  
Hiroyuki Fukuda ◽  
Masaharu Yoshikawa ◽  
Nobuyuki Sugiura ◽  
Hiromitsu Saisho

1993 ◽  
Vol 34 (1) ◽  
pp. 26-29 ◽  
Author(s):  
S. Savastano ◽  
G. P. Feltrin ◽  
D. Neri ◽  
P. da Pian ◽  
M. Chiesura-Corona ◽  
...  

Thirty-three consecutive patients with previously untreated hepatocellular carcinoma (HCC) and 6 patients with recurrent HCC were treated with transcatheter arterial embolization (TAE). The patients were not eligible for surgical resection or percutaneous ethanol injection. TAE was performed with Lipiodol Ultra-Fluid, epidoxorubicin and Gelfoam, with a mean of 1.7 treatments per patient. CT was performed 15 days after TAE. The mean cumulative survival was 14.2 months in patients with previously untreated HCC. The survival of patients stages Okuda I and II did not differ significantly (p > 0.05); tumor size did not affect survival (p > 0.05). Two patients with recurrent HCC died 7.0 and 9.3 months after the diagnosis of tumor recurrence; the remaining 4 patients are still alive with a maximum follow-up of 22.5 months from the diagnosis of HCC recurrence. Ten complications occurred in 8 patients, and were controlled by medical therapy. Eleven patients died during the study; no death was related to TAE. The series was not randomized, but comparison with the natural history of HCC suggests that TAE is effective as palliative treatment of advanced or recurrent HCC.


Author(s):  
M. Romero-Gutiérrez ◽  
T. Artaza-Varasa ◽  
R. A. Gómez- Rodríguez ◽  
C. González-de-Frutos ◽  
A. Z. Gómez-Moreno

Sign in / Sign up

Export Citation Format

Share Document